Leadership
Meet our team of leading scientists and business experts driving the innovation at ReForm Biologics.Management Team

John M. Sorvillo Ph.D. - Chief Executive Officer

David Soane, Ph.D. - Chief Technology Officer, Co-founder

Bob Gallahue - Chief Financial Officer
Mr. Gallahue has over 25 years of financial management experience in public and private biotechnology and medical technology companies in the various facets of start‐up through public company environments, including three IPOs, three mergers, joint ventures, private financings and follow‐on offerings. Mr. Gallahue has served as CFO of CorNova, Inc., Molecular Insight, and Keryx Biopharmaceuticals and has worked in high level financial positions at Millennium Pharmaceuticals and LeukoSite Inc. Mr. Gallahue started his career at PricewaterhouseCoopers, LLP where he was a C.P.A. responsible for auditing. Mr. Gallahue holds a M.S.A. from Bentley College and B.A. from Middlebury College.

Robert Mahoney, Ph.D. - VP of Research and Development

Sharon Webb, M.D., Ph.D., J.D. - VP of Intellectual Property
Board of Directors
James Sherblom - Chairman
Dr. Jim Sherblom is an entrepreneur, social impact investor, spiritual seeker, and transcendentalist. Jim was a founder of the Massachusetts Biotechnology Council and served as its second President. As Senior Vice President and Chief Financial Officer of Genzyme Corporation Jim led their initial public offering and helped create many of the early biotechnology industry’s most innovative financing structures. As Chairman and CEO of Transgenic Sciences Inc. he led a ten-fold growth of this company over a period of five years. As founding Managing Partner of Seaflower Ventures Jim has been involved as a founder, early investor, board member, or board chair of over a dozen early stage biotechnology, life science, and social impact companies over the last three decades. Jim currently serves as the largest investor and CFO of GrainPro Inc. and also on the board of Connected Homecare Inc. Jim holds a BA from Yale, an MBA from Harvard, and Master of Divinity and Doctor of Ministry degrees from Andover Newton Theological School.
John M. Sorvillo Ph.D. - Chief Executive Officer
David Soane, Ph.D. - Chief Technology Officer, Co-founder
Zach Jonasson, Ph.D. - Co-founder
V. Bryan Lawlis, Ph.D.
Scientific Advisors
Andrew Jones, D. Phil.
Mark Moody, Ph.D.
Neil Schauer, Ph.D.
John Carpenter Ph.D.
Alan Herman, Ph.D.
Dr. Herman has over 35 years of experience in the life sciences sector and expert in protein characterization. He was most recently Chief Scientific Officer at Coherus Biosciences, a leading biopharmaceutical company developing safe, high-quality biosimilar therapeutics. Previously, he was Vice President of Product Development and CSO at Althea Technologies and President of WindRose Analytica, Inc. Dr. Herman worked a number of other biotech companies, including Genentech and Amgen. He has a Ph.D. in Protein Chemistry from Duke University.